Divya Yerraguntla | Angel Investor
Life Science Angels

Divya Yerraguntla is a dynamic and accomplished professional with a robust background in commercialization and Strategy. She is currently an Angel investor with Life Sciences Angel(LSA) and an Advisor with a leading strategic consulting and advisory firm, where she focuses on development and commercialization strategies that realize and maximize net present value (NPV) and transactability with both financial and strategic players. Divya's extensive experience spans over 25 years within the Pharmaceutical industry. She has worked with companies such as Johnson & Johnson, Novo Nordisk, SUN Pharma, and Syneos Health, where she has honed her expertise in driving business growth and creating value through innovative commercialization strategies. She has a proven track record of leading cross-functional teams and managing complex projects, ensuring products reach the market and thrive in competitive landscapes. Her career highlights include successfully launching 30+ Pharmaceutical products across 11 markets, leveraging her deep understanding of market dynamics, regulatory landscapes, and investment strategies. Divya's ability to bridge the gap between technical innovation and market needs has made her a sought-after advisor in the industry. In her current role, Divya collaborates with a diverse range of clients, from early-stage ventures to established corporations, helping them navigate the intricacies of market entry, product launch, and growth acceleration. Her real-world experience enables her to provide nuanced, actionable advice that drives measurable results. She is a seasoned speaker and chairperson at various pharma forums and conferences, an advisor, and a board member. She also hosts the “Woman to Woman” podcast series, which provides support and guidance to women professionals and executives.